Crinetics Pharmaceuticals, Inc. Increase (Decrease) in Other Operating Liabilities
Crinetics Pharmaceuticals, Inc. (CRNX) reported Increase (Decrease) in Other Operating Liabilities of $17.81 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2025-11-06
- 2025-09-30: Increase (Decrease) in Other Operating Liabilities 9 month $17.81M.
- 2024-09-30: Increase (Decrease) in Other Operating Liabilities 9 month $7.20M.
| Period end | Increase (Decrease) in Other Operating Liabilities 9 month |
|---|---|
| 2025-09-30 | $17.81M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $7.20M 10-Q · filed 2025-11-06 |